SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001659617-20-000128
Filing Date
2020-05-11
Accepted
2020-05-11 16:36:00
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mbx-20200331.htm   iXBRL 10-Q 1106008
2 EX-31.1 a2020q1ex311-xnextgen.htm EX-31.1 12591
3 EX-31.2 a2020q1ex312-xnextgen.htm EX-31.2 12298
4 EX-32.1 a2020q1ex321-xnextgen.htm EX-32.1 7267
5 EX-32.2 a2020q1ex322-xnextgen.htm EX-32.2 7369
11 mbx-20200331_g1.jpg GRAPHIC 132868
  Complete submission text file 0001659617-20-000128.txt   5421239

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbx-20200331.xsd EX-101.SCH 37627
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbx-20200331_cal.xml EX-101.CAL 55693
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbx-20200331_def.xml EX-101.DEF 167540
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbx-20200331_lab.xml EX-101.LAB 440784
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbx-20200331_pre.xml EX-101.PRE 284689
24 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20200331_htm.xml XML 902034
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 20865423
SIC: 2834 Pharmaceutical Preparations